StockScan › Stocks › TWST
Diagnostics
TWST
87.06
  Price8.84%   -8.44
(Pre-market: .00 -87.06 -100.00%)
KEY STATS
Previous Close:
$95.50
Market Cap:
$4.32B
24h Volume:
642.09K
1D Range:
$86.86 - $97.70
52W Range:
$84.23 - $214.07
Primary Exchange:
COMPANY PROFILE
NameNameTwist Bioscience Corporation
SectorHealthcare (1214)
IndustryDiagnostics & Research (92)
Webtwistbioscience.com
Phone800-719-0671
Employee221
Twitter @TwistBioscience
Latest SEC Filings
TWST's Discussions on Twitter
455 Mission Bay Boulevard South, Suite 545, San Francisco, CA, United States (94158)
News Options Financials Holders Transactions Discussions Predictions
Dec-01-21 08:00AM Cathie Wood Likes Fate Therapeutics, Should You?The Motley Fool
Nov-23-21 09:31AM Company News for Nov 23, 2021Zacks Investment Research
Nov-22-21 05:30AM Twist Bioscience Corporation (TWST) Q4 2021 Earnings Call TranscriptThe Motley Fool
04:51AM Twist Bioscience stock prediction after plunging 8% on earnings missInvezz
Nov-22-21 08:45AM Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research
Nov-21-21 03:04AM The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened WeekBenzinga
Nov-15-21 03:00AM Earnings Preview: Twist Bioscience (TWST) Q4 Earnings Expected to DeclineZacks Investment Research
Oct-01-21 02:08AM Confidence In My Growth Portfolio Continues: My Q3 Total Portfolio BreakdownSeeking Alpha
Sep-23-21 05:52AM Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 YearsThe Motley Fool
Sep-19-21 09:31AM 2 Biotech Stocks to Buy Right NowThe Motley Fool
Sep-18-21 09:15AM A Second Week of Declines as September ContinuesZacks Investment Research
Aug-06-21 08:30AM Twist Bioscience Corporation (TWST) Q3 2021 Earnings Call TranscriptThe Motley Fool
10:00AM Is Cathie Wood's ARKK ETF a Buy Now?The Motley Fool
Aug-06-21 07:42AM The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPOBenzinga
Aug-01-21 10:13AM The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOsBenzinga
Jul-30-21 03:00AM Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research
Jul-06-21 12:26PM Forensic Value Stock Selections: Top Positive And Negative Scoring Stocks For Mid-Year 2021Seeking Alpha
Jun-30-21 09:15AM Slow Trading Can't Stop S&P, NASDAQ From Setting New RecordsZacks Investment Research
Jun-28-21 08:15AM The 20 best-performing IPOs of the past three years have returned up to 1,477%MarketWatch
Jun-26-21 04:31AM The 20 best-performing IPOs of the past three years have returned up to 1,477%MarketWatch
Jun-25-21 08:14AM The 20 best-performing IPOs of the past three years have returned up to 1,477%MarketWatch
07:17AM The 20 best-performing IPOs of the past three years have returned up to 1,477%MarketWatch
Jun-24-21 11:11AM The 20 best-performing IPOs of the past three years have returned up to 1,477%MarketWatch
Jun-06-21 07:31AM The Best Stocks to Buy in Cathie Wood's ARK Genomic Revolution ETFThe Motley Fool
About Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.
List of SPAC Stocks List of EV Stocks and Related Stocks Top 100 popular stocks on Robinhood List of Marijuana Stocks
Open in Yahoo | Open in Google | Open in Finviz
Cap:    |  Volume (24h):